0001437749-24-015399.txt : 20240508
0001437749-24-015399.hdr.sgml : 20240508
20240508165148
ACCESSION NUMBER: 0001437749-24-015399
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240506
FILED AS OF DATE: 20240508
DATE AS OF CHANGE: 20240508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeMaitre George W
CENTRAL INDEX KEY: 0001365737
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 24927101
MAIL ADDRESS:
STREET 1: 342 BUNKER HILL STREET, #2B
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 SECOND AVENUE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-06
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365737
LeMaitre George W
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
1
1
Chairman and CEO
1
Common Stock
2024-05-06
4
S
0
23206
76.1211
D
2179128
D
Common Stock
2024-05-06
4
S
0
29500
75.2308
D
2149628
D
Common Stock
2024-05-06
4
S
0
16200
75.9406
D
2133428
D
Common Stock
2024-05-07
4
S
0
26044
75.2389
D
2107384
D
Common Stock
2024-05-07
4
S
0
20256
75.856
D
2087128
D
Common Stock
2024-05-08
4
S
0
8000
75.30340
D
2079128
D
Adoption date of referenced 10b5-1(c) plan is: 06-02-2023
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.01 to $76.24. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.68 to $75.635. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.6846 to $76.23. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.5584 to $75.5484. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.55 to $76.085. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.9289 to $75.66. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
/s/ Nathaniel R.J. Ulrich
2024-05-08